CVE-2014-9701

Description

Cross-site scripting (XSS) vulnerability in MantisBT before 1.2.19 and 1.3.x before 1.3.0-beta.2 allows remote attackers to inject arbitrary web script or HTML via the url parameter to permalink_page.php.

Category

6.5
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.77% Top 30%
Vendor Advisory mantisbt.org Vendor Advisory mantisbt.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://www.mantisbt.org/bugs/view.php?id=19493 vendor advisory
http://www.openwall.com/lists/oss-security/2015/03/15/2 mailing list third party advisory patch
https://bugzilla.redhat.com/show_bug.cgi?id=1202885 issue tracking patch vdb entry third party advisory
https://www.mantisbt.org/bugs/view.php?id=17362#c40613 vendor advisory
https://github.com/mantisbt/mantisbt/commit/d95f070db852614fa18ccca6a4f12f4bffede1fd third party advisory patch
https://github.com/mantisbt/mantisbt/commit/e7e2b5503580e42db9d91e0d599d61d3ff03c27e third party advisory patch

Frequently Asked Questions

What is the severity of CVE-2014-9701?
CVE-2014-9701 has been scored as a medium severity vulnerability.
How to fix CVE-2014-9701?
To fix CVE-2014-9701, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2014-9701 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2014-9701 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.